Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ABBONews Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::102177005.png) ABBO News [@ABBONews](/creator/twitter/ABBONews) on x 14K followers
Created: 2025-07-16 12:46:25 UTC

🚨Shares in Focus: Johnson & Johnson $JNJ shares are up XXXX% pre-market to $XXXXXX after beating Q2 earnings. 

💰EPS came in at $2.77, compared to the $XXXX consensus estimate.
📈Revenue reached $XXXXX billion, surpassing forecasts, driven by strong demand for cancer drug Darzalex and medical device strength. Full-year sales forecast raised.

![](https://pbs.twimg.com/media/Gv-uI18XsAA0qc9.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945465041031246276/c:line.svg)

**Related Topics**
[jnj](/topic/jnj)
[sales forecast](/topic/sales-forecast)
[eps](/topic/eps)
[$jnj](/topic/$jnj)
[stocks](/topic/stocks)
[johnson johnson](/topic/johnson-johnson)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/ABBONews/status/1945465041031246276)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ABBONews Avatar ABBO News @ABBONews on x 14K followers Created: 2025-07-16 12:46:25 UTC

🚨Shares in Focus: Johnson & Johnson $JNJ shares are up XXXX% pre-market to $XXXXXX after beating Q2 earnings.

💰EPS came in at $2.77, compared to the $XXXX consensus estimate. 📈Revenue reached $XXXXX billion, surpassing forecasts, driven by strong demand for cancer drug Darzalex and medical device strength. Full-year sales forecast raised.

XXX engagements

Engagements Line Chart

Related Topics jnj sales forecast eps $jnj stocks johnson johnson stocks healthcare

Post Link

post/tweet::1945465041031246276
/post/tweet::1945465041031246276